Trump says Nvidia not allowed to sell advanced AI chips to China- 60 Minutes
LONDON - Xtrackers (IE) plc announced Thursday it will delist six of its exchange-traded fund (ETF) share classes from the SIX Swiss Exchange effective February 6, 2026, citing "sustained low amount of trading turnover" as the reason for discontinuation.
The affected ETFs include the company’s EUR High Yield Corporate Bond SRI PAB, MSCI Fintech Innovation, MSCI Genomic Healthcare Innovation, MSCI Innovation, MSCI Next Generation Internet Innovation, and USD High Yield Corporate Bond Screened UCITS ETFs.
February 5, 2026, will be the final trading day for these share classes on the Swiss exchange. After this date, the ETFs will remain listed on other exchanges including XETRA, London Stock Exchange, and Borsa Italiana.
DWS CH AG, acting as Swiss Representative for the funds, also confirmed the voluntary discontinuation of distribution to non-qualified investors in Switzerland, as no share classes of these funds will remain listed on a Swiss stock exchange after the delisting date.
Shareholders who wish to continue trading these ETFs after the delisting will need to instruct their intermediary bank or stockbroker to realign their shares to one of the remaining exchanges where the ETFs will continue to be listed. The company noted that intermediaries may impose administration charges for this realignment.
The board of directors emphasized that the delisted share classes will not be terminated or compulsorily redeemed, and advised shareholders to consult with tax advisors regarding potential implications of these changes.
The announcement was made in a press release statement from Xtrackers (IE) plc, an investment company with variable capital registered in Ireland.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.